China Respiratory Devices Market Size (2024 - 2029)

China Respiratory Devices Market Analysis

The China respiratory devices market is expected to register a CAGR of 12.5% over the forecast period.

With collective measures, scientific approaches, and public awareness, China dealt with the first wave of the COVID-19 pandemic in 2020. The second pandemic wave has undoubtedly resulted in a regional shortage of medical oxygen. For instance, in May 2021, China exported over 26,000 ventilators and oxygen concentrators, over 15,000 patient monitors, and nearly 3,800 tons of medicinal materials and medicines to India. Chinese companies received Indian orders for over 70,000 oxygen concentrators. Such a surge in demand drove the growth of the market. However, the market lost some traction as COVID-19 cases declined in the first three quarters of the year 2022 as the COVID-19 pandemic accelerated the use of respiratory devices. However, with the re-elevation of COVID-19 cases in China, the demand for respiratory devices is expected to create lucrative opportunities for the growth of the China respiratory device market in the studied period.

The major driving factors include the high prevalence of respiratory diseases in China, the continuation of economic and demographic trends, technological advancements, and increasing applications in-home care settings. For instance, as per an article published by the National Library of Medicine, in October 2021, COPD remains an important public health problem in China. Effective prevention and control measures are likely to strengthen to raise the standard of living for chronic obstructive pulmonary disease (COPD) patients and lower the number of COPD-related premature deaths among the Chinese population. So, there is a high chance of adopting sophisticated respiratory devices within the population which will lead to market growth in China. Furthermore, the study published by BMC Pulmonary Medicine, in March 2022, supports the fact that there is good agreement and reproducibility between the measurements from the portable and traditional respiratory devices. A trustworthy tool for screening and diagnosing chronic airway diseases in primary care settings is the portable spirometer. Such a study to evaluate the effectiveness of the devices in China is expected to open up enormous opportunities for market participants and accelerate market growth.

Additionally, the increasing initiatives, product launches, and strategies by market players in China are also expected to contribute to the market's growth. For instance, in December 2021, Aerogen Pharma and Nuance Pharma signed an agreement to join forces in Greater China to develop a superior, non-invasive approach to the treatment of Respiratory Distress Syndrome, a life-threatening condition of preterm infants associated with long-term lung health issues in survivors. Also, in July 2022, a group of chronic obstructive pulmonary disease (COPD) patients in China underwent surgery using Broncus Medical's InterVapor system, the device's first use in the country since its approval by Chinese regulators in March 2022. Such development is expected to drive the growth of the market over the forecast period.

Hence, as to the factors such as the high prevalence of respiratory diseases in China, the continuation of economic and demographic trends, technological advancements, and increasing applications in-home care settings, China's respiratory devices market is anticipated to grow over the forecast period. However, the high cost associated with respiratory devices is likely to restrain the market growth.

China Respiratory Devices Industry Segmentation

As per the scope, respiratory devices refer to the supply of respiratory gas mechanically to patients with impaired respiratory function. The respiratory gas is usually enriched with oxygen and conveyed into the lung with a positive pressure generated by the device. The China Respiratory Devices Market is segmented by Type (Diagnostic and Monitoring Devices, Therapeutic Devices, and Disposables). The report offers the value (in USD million) for the above segments.